Ono Pharma Seeks Approval for Ripretinib in GIST Patients Japan
Ono Pharmaceutical Co., Ltd. that Ono submitted an application for the manufacturing and marketing approval of ripretinib (DCC-2618), developed by Deciphera Pharmaceuticals, Inc. (“Deciphera”), for...